While the measles vaccine is highly effective at preventing the disease, a very small portion — less than 1% — of infectious ...

Exciting new research by Baker Heart and Diabetes Institute researchers raises the possibility that we could reduce the severity of heart failure and ...

The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...

The convergence of AI and drug delivery is opening new frontiers in precision medicine. AI-powered predictive modeling is ...

Zhittya Genesis Medicine proudly announces that Dr. Jack Jacobs, President and Chief Science Officer, will be honored by NevadaBio at its Annual Awards Dinner on Wednesday, April 2, 2025, at 5:30 pm ...

Breakthrough T1D Canada is calling on the Quebec government to adopt the 2022 INESSS recommendation to eliminate current age restrictions on public coverage of insulin pumps and extend access to all ...

Scientists have made a potentially “life-changing” discovery that could pave the way for new drugs to treat Parkinson’s ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first targeted therapy ever ...

Johnson & Johnson announced that the U.S. FDA has granted investigational nipocalimab Fast Track designation for the treatment of adult ...

Researchers have discovered more about PINK1, a protein that’s directly tied to Parkinson’s disease. A team from Walter and Eliza Hall Institute in Australia has shown how the protein attaches to cell ...